19 May 2022 Key facts Vaccines used during the smallpox eradication programme also provided protection against monkeypox. Newer vaccines have been developed of which one has been approved for prevention of monkeypoxMonkeypox is caused by monkeypox virus, a member of...
14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
New estimates from the World Health Organization (WHO) show that the full death toll associated directly or indirectly with the COVID-19 pandemic (described as “excess mortality”) between 1 January 2020 and 31 December 2021 was approximately 14.9 million (range 13.3...
WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator
Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date. However,...
WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs
Solidarity PLUS trial for promising drugs will roll out in 52 countries, an unprecedented global collaboration for COVID-19 R&D The World Health Organization (WHO) has announced the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized...
WHO announces simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
May 31, 2021 WHO announces simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern WHO has assigned simple, easy to say and remember labels for key variants of SARS-CoV-2, the virus that causes COVID-19, using letters of the Greek alphabet. These...